Annual EBITDA:
-$173.63M-$136.60M(-368.90%)Summary
- As of today, SLNO annual EBITDA is -$173.63 million, with the most recent change of -$136.60 million (-368.90%) on December 31, 2024.
- During the last 3 years, SLNO annual EBITDA has fallen by -$143.34 million (-473.12%).
- SLNO annual EBITDA is now -21471.87% below its all-time high of -$804.90 thousand, reached on December 31, 2013.
Performance
SLNO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$23.22M+$28.14M(+571.78%)Summary
- As of today, SLNO quarterly EBITDA is $23.22 million, with the most recent change of +$28.14 million (+571.78%) on September 30, 2025.
- Over the past year, SLNO quarterly EBITDA has increased by +$102.06 million (+129.46%).
- SLNO quarterly EBITDA is now at all-time high.
Performance
SLNO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$82.26M+$102.06M(+55.37%)Summary
- As of today, SLNO TTM EBITDA is -$82.26 million, with the most recent change of +$102.06 million (+55.37%) on September 30, 2025.
- Over the past year, SLNO TTM EBITDA has increased by +$54.24 million (+39.74%).
- SLNO TTM EBITDA is now -4447.73% below its all-time high of $1.89 million, reached on March 31, 2013.
Performance
SLNO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLNO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -368.9% | +129.5% | +39.7% |
| 3Y3 Years | -473.1% | +519.3% | -257.3% |
| 5Y5 Years | -717.5% | +456.1% | -189.0% |
SLNO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -685.6% | at low | at high | +129.5% | -259.2% | +59.3% |
| 5Y | 5-Year | -717.5% | at low | at high | +129.5% | -259.2% | +59.3% |
| All-Time | All-Time | >-9999.0% | at low | at high | +129.5% | -4447.7% | +59.3% |
SLNO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $23.22M(+571.8%) | -$82.26M(+55.4%) |
| Jun 2025 | - | -$4.92M(+88.4%) | -$184.31M(+8.8%) |
| Mar 2025 | - | -$42.27M(+27.5%) | -$202.13M(-10.8%) |
| Dec 2024 | -$173.63M(-368.9%) | -$58.29M(+26.1%) | -$182.44M(-33.7%) |
| Sep 2024 | - | -$78.83M(-246.7%) | -$136.50M(-105.4%) |
| Jun 2024 | - | -$22.74M(-0.7%) | -$66.47M(-29.2%) |
| Mar 2024 | - | -$22.58M(-83.0%) | -$51.44M(-41.1%) |
| Dec 2023 | -$37.03M(-67.5%) | -$12.34M(-40.2%) | -$36.46M(-22.3%) |
| Sep 2023 | - | -$8.80M(-14.2%) | -$29.81M(-12.3%) |
| Jun 2023 | - | -$7.71M(-1.4%) | -$26.55M(-8.6%) |
| Mar 2023 | - | -$7.60M(-33.5%) | -$24.43M(-6.7%) |
| Dec 2022 | -$22.10M(+27.0%) | -$5.69M(-2.8%) | -$22.90M(+0.5%) |
| Sep 2022 | - | -$5.54M(+1.1%) | -$23.02M(+6.6%) |
| Jun 2022 | - | -$5.60M(+7.7%) | -$24.66M(+7.1%) |
| Mar 2022 | - | -$6.07M(-4.4%) | -$26.54M(+11.7%) |
| Dec 2021 | -$30.30M(-1.0%) | -$5.81M(+19.0%) | -$30.05M(+4.6%) |
| Sep 2021 | - | -$7.17M(+4.2%) | -$31.49M(-2.1%) |
| Jun 2021 | - | -$7.49M(+21.8%) | -$30.84M(+1.0%) |
| Mar 2021 | - | -$9.58M(-32.0%) | -$31.15M(-4.8%) |
| Dec 2020 | -$30.00M(-41.2%) | -$7.26M(-11.3%) | -$29.71M(-4.4%) |
| Sep 2020 | - | -$6.52M(+16.3%) | -$28.46M(-3.3%) |
| Jun 2020 | - | -$7.79M(+4.3%) | -$27.55M(-11.5%) |
| Mar 2020 | - | -$8.14M(-35.6%) | -$24.71M(-18.5%) |
| Dec 2019 | -$21.24M | -$6.00M(-6.9%) | -$20.85M(-16.4%) |
| Sep 2019 | - | -$5.62M(-13.4%) | -$17.92M(-15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$4.95M(-15.6%) | -$15.46M(-14.5%) |
| Mar 2019 | - | -$4.28M(-39.6%) | -$13.50M(-14.7%) |
| Dec 2018 | -$11.77M(-4.7%) | -$3.07M(+2.9%) | -$11.77M(-8.7%) |
| Sep 2018 | - | -$3.16M(-5.7%) | -$10.83M(-10.0%) |
| Jun 2018 | - | -$2.99M(-17.0%) | -$9.84M(-5.0%) |
| Mar 2018 | - | -$2.56M(-20.2%) | -$9.37M(-16.1%) |
| Dec 2017 | -$11.24M(-35.3%) | -$2.13M(+2.2%) | -$8.07M(+9.0%) |
| Sep 2017 | - | -$2.17M(+13.7%) | -$8.86M(-1.8%) |
| Jun 2017 | - | -$2.52M(-100.7%) | -$8.70M(-3.0%) |
| Mar 2017 | - | -$1.25M(+57.0%) | -$8.44M(+26.1%) |
| Dec 2016 | -$8.31M(+31.1%) | -$2.92M(-45.0%) | -$11.43M(+4.3%) |
| Sep 2016 | - | -$2.01M(+11.0%) | -$11.95M(+8.7%) |
| Jun 2016 | - | -$2.26M(+46.7%) | -$13.09M(+6.0%) |
| Mar 2016 | - | -$4.24M(-23.5%) | -$13.93M(-15.1%) |
| Dec 2015 | -$12.05M(-32.7%) | -$3.43M(-8.9%) | -$12.09M(-15.2%) |
| Sep 2015 | - | -$3.15M(-2.0%) | -$10.50M(-21.2%) |
| Jun 2015 | - | -$3.09M(-28.3%) | -$8.66M(-26.1%) |
| Mar 2015 | - | -$2.41M(-31.3%) | -$6.86M(-33.8%) |
| Dec 2014 | -$9.08M(-1027.9%) | -$1.84M(-39.5%) | -$5.13M(-55.8%) |
| Sep 2014 | - | -$1.32M(-1.3%) | -$3.29M(-66.6%) |
| Jun 2014 | - | -$1.30M(-91.8%) | -$1.98M(-7.2%) |
| Mar 2014 | - | -$677.70K(+41.9%) | -$1.84M(-354.2%) |
| Dec 2013 | -$804.90K(+77.5%) | - | - |
| Jun 2013 | - | -$1.17M(-161.7%) | $725.40K(-61.7%) |
| Mar 2013 | - | $1.89M | $1.89M |
| Dec 2012 | -$3.57M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Soleno Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Soleno Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of SLNO is -$173.63M
What is the all-time high annual EBITDA for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual EBITDA is -$804.90K
What is Soleno Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, SLNO annual EBITDA has changed by -$136.60M (-368.90%)
What is Soleno Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of SLNO is $23.22M
What is the all-time high quarterly EBITDA for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly EBITDA is $23.22M
What is Soleno Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, SLNO quarterly EBITDA has changed by +$102.06M (+129.46%)
What is Soleno Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of SLNO is -$82.26M
What is the all-time high TTM EBITDA for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM EBITDA is $1.89M
What is Soleno Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, SLNO TTM EBITDA has changed by +$54.24M (+39.74%)